New perspective of the treatment of <i>Helicobacter pylori</i> infection

Franciszek Iwańczak; Barbara Iwańczak

doi:10.5114/pg.2011.25991

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

6/2011
vol. 6

Send email

Copy url:

abstract:

Review paper

**New perspective of the treatment of Helicobacter pylori infection**

Franciszek Iwańczak

,

Barbara Iwańczak

Przegląd Gastroenterologiczny 2011; 6 (6): 364–369

DOI: https://doi.org/10.5114/pg.2011.25991

Online publish date: 2011/12/03

View full text Get citation

PlumX metrics:

In the present review the influence of certain factors on the effectiveness of treatment course and new possibilities of medication of Helicobacter pylori infections are outlined. Increasing resistance against clarithromycin and high resistance against metronidazole pose the greatest challenge. Therefore, the choice of the proper set of antibiotics and chemotherapeutics is of the greatest importance. The authors present the results of eradication depending on treatment schemas. The authors also direct attention at the importance of the duration of the treatment and compliance of patients in fulfilment of medical advice. Results of treatment effectiveness with tetracycline, bismuth, levofloxacin, moxifloxacin, and other medicaments are presented. Sequence therapy and recommendations for the treatment of H. pylori infection of the Working Group of the Polish Society of Gastroenterology are discussed.

keywords:

New perspective of the treatment of Helicobacter pylori infection

Franciszek Iwańczak , Barbara Iwańczak

Helicobacter pylori, resistance, compliance, eradication, sequential therapy

**New perspective of the treatment of Helicobacter pylori infection**

Franciszek Iwańczak

,

Barbara Iwańczak